Pegcrisantaspase in Combination with Venetoclax for Treatment of Relapsed or Refractory Acute Myeloid Leukemia: A Phase 1 Study

被引：0
|
作者：
Niyongere, Sandrine [1 ,2 ]
Duong, Vu H. [2 ,3 ]
Bollino, Dominique R. [1 ]
Lapidus, Rena G. [1 ]
Strovel, Erin T. [4 ]
Zarrabi, Jinoos [1 ]
Bah, Osman Mohamed [1 ]
Philip, Sunita [1 ]
Kflu, Veronica [1 ]
Baer, Maria R. [2 ,3 ]
Emadi, Ashkan [1 ,2 ]
机构：
[1] Univ Maryland, Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA
[3] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
[4] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-150728
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4433
引用
收藏
页数：4
相关论文
共 50 条
  • [1] A phase 1 study of the amino acid modulator pegcrisantaspase and venetoclax for relapsed or refractory acute myeloid leukemia
    Liu, Yuchen
    Bollino, Dominique R.
    Bah, Osman M.
    Strovel, Erin T.
    Le, Tien, V
    Zarrabi, Jinoos
    Philip, Sunita
    Lapidus, Rena G.
    Baer, Maria R.
    Niyongere, Sandrine
    Duong, Vu H.
    Dougherty, Christine C.
    Beumer, Jan H.
    Caprinolo, Katherine D.
    Kamangar, Farin
    Emadi, Ashkan
    BLOOD, 2025, 145 (05) : 486 - 496
  • [2] Phase 1 Dose Escalation Trial of Pegcrisantaspase in Combination with Venetoclax in Adults with Relapsed or Refractory Acute Myeloid Leukemia
    Bollino, Dominique R.
    Liu, Yuchen
    Bah, Osman Mohamed
    Caprinolo, Katherine
    Zarrabi, Jinoos
    Philip, Sunita
    Mostafa, Ezzat
    Lapidus, Rena G.
    Singh, Zeba
    Kallen, Michael
    Ning, Yi
    Koka, Rima
    Baer, Maria R.
    Niyongere, Sandrine
    Duong, Vu H.
    Strovel, Erin T.
    Graveno, Molly
    Emadi, Ashkan
    BLOOD, 2022, 140 : 9044 - 9045
  • [3] Venetoclax Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia
    Brancati, Serena
    Gozzo, Lucia
    Romano, Giovanni Luca
    Vetro, Calogero
    Dulcamare, Ilaria
    Maugeri, Cinzia
    Parisi, Marina
    Longo, Laura
    Vitale, Daniela Cristina
    Di Raimondo, Francesco
    Drago, Filippo
    BLOOD, 2021, 138
  • [4] Venetoclax in Combination with Gilteritinib in Patients with Relapsed/Refractory Acute Myeloid Leukemia: A Phase 1b Study
    Perl, Alexander E.
    Daver, Naval G.
    Pratz, Keith W.
    Maly, Joseph
    Hong, Wan-Jen
    Bahceci, Erkut
    Tong, Bo
    Tian, Tian
    Dilley, Kimberley
    BLOOD, 2019, 134
  • [5] Venetoclax in combination with azacitidine or decitabine in relapsed/refractory acute myeloid leukemia
    Che, Yue
    Tan, Wanqing
    Liu, Ying
    Liu, Haitao
    Li, Lanlan
    Qin, Fangmei
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2024, 23 (01) : 209 - 214
  • [6] Novel Combination Therapy of Venetoclax and Ruxolitinib in the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia
    Borate, Uma
    Saultz, Jennifer N.
    Kaempf, Andy
    Minnier, Jessica
    Tognon, Cristina E.
    Kurtz, Stephen E.
    Eide, Christopher A.
    Patel, Prapti A.
    Madanat, Yazan F.
    Clement, Peter
    Avaylon, Sammantha
    Misra, Shikha
    Druker, Brian J.
    Tyner, Jeffrey W.
    BLOOD, 2021, 138
  • [7] A Phase I/II Study of Sapacitabine and Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia
    Desikan, Sai Prasad
    Kantarjian, Hagop
    DiNardo, Courtney D.
    Borthakur, Gautam
    Daver, Naval
    Pemmaraju, Naveen
    Alvarado, Yesid
    Burger, Jan A.
    Linderman, Debra Bull
    Pierce, Sherry A.
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Kadia, Tapan M.
    BLOOD, 2021, 138
  • [8] Chidamide in Combination With DCAG With or Without Venetoclax for Relapsed/Refractory Acute Myeloid Leukemia
    Liu, Qingyang
    Zhang, Xiawei
    Lv, Lei
    Xu, Linming
    Jing, Yu
    Gao, Wenjing
    Wang, Lili
    Dou, Liping
    CANCER MEDICINE, 2025, 14 (05):
  • [9] Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia
    Aldoss, Ibrahim
    Yang, Dongyun
    Aribi, Ahmed
    Ali, Haris
    Sandhu, Karamjeet
    Al Malki, Monzr M.
    Mei, Matthew
    Salhotra, Amandeep
    Khaled, Samer
    Nakamura, Ryotaro
    Snyder, David
    O'Donnell, Margaret
    Stein, Anthony S.
    Forman, Stephen J.
    Marcucci, Guido
    Pullarkat, Vinod
    HAEMATOLOGICA, 2018, 103 (09) : E404 - E407
  • [10] A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemia
    Jonas, Brian A.
    Hou, Jing-Zhou
    Roboz, Gail J.
    Alvares, Caroline L.
    Jeyakumar, Deepa
    Edwards, John R.
    Erba, Harry P.
    Kelly, Richard J.
    Roellig, Christoph
    Fiedler, Walter
    Brackman, Deanna
    Siddani, Satya R.
    Chyla, Brenda
    Hilger-Rolfe, Jacqueline
    Watts, Justin M.
    HEMATOLOGICAL ONCOLOGY, 2023, 41 (04) : 743 - 752
12345